Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,953 total articles
Lemonade, a tech-driven insurance company listed on NYSE as LMND, has expanded its renters insurance product to Louisiana. The service offers customizable coverage through a mobile app at prices starting around $5 monthly, significantly lower than average market rates. This move marks another step in Lemonade's nationwide growth, targeting renters …
Kura Oncology and Kyowa Kirin will present updated Phase 1 KOMET-007 trial results showing high and durable response rates of ziftomenib in combination with standard chemotherapy (7+3) in newly diagnosed acute myeloid leukemia (AML) patients with NPM1 mutations or KMT2A rearrangements. The data feature a 96% complete response rate and deep molecula…
Skyward Specialty Insurance Group appoints Melissa Goto as President of E&S Brokerage and Inland Marine divisions, aiming to leverage her 25+ years of underwriting and leadership expertise to enhance strategic development and market position in specialty property and casualty insurance.
Aquestive Therapeutics has completed a new $150 million debt financing agreement with Oaktree Capital Management, providing improved financial flexibility by reducing near-term principal repayments and lowering interest rates. This capital structure enhancement is aimed at supporting the potential FDA approval and launch of Anaphylm, a novel sublin…
Geron Corporation announced the presentation of the first real-world evidence study of RYTELO (imetelstat) in patients with lower-risk myelodysplastic syndromes (LR-MDS) at the EHA 2026 Congress. The study, conducted at Moffitt Cancer Center, demonstrated safety and clinical efficacy consistent with the Phase 3 IMerge trial, including in heavily tr…
Agios Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking accelerated approval for mitapivat, an oral pyruvate kinase activator, for the treatment of sickle cell disease. The submission follows FDA agreement on a confirmatory trial designed to demonstrate the drug's clinical benefit in reducing transfusion bu…
Star Bulk Carriers Corp., a major global dry bulk shipping company, has announced the results of its 2026 Annual Meeting of Shareholders held in Athens, Greece. The company reported the re-election of key directors and the appointment of Deloitte Certified Public Accountants S.A. as its independent auditors for the fiscal year 2026. Star Bulk highl…
Cogent Biosciences announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including pivotal oral presentation data from the APEX trial of bezuclastinib in Advanced Systemic Mastocytosis and preclinical data for their JAK2 V617F inhibitor program. These presentations underscore the company's progress in developi…
Disc Medicine announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including an oral presentation of phase 2 RALLY-MF trial data for DISC-0974 targeting anemia in myelofibrosis patients. The company also highlighted updates on bitopertin in erythropoietic protoporphyria (EPP) and ongoing trials for polycythem…
Caribou Biosciences announced that two of its investigational allogeneic CAR-T cell therapies, vispa-cel and CB-011, will be featured in oral presentations at the 2026 European Hematology Association Annual Meeting. These presentations will share updated clinical trial data demonstrating the therapies' potential in treating relapsed or refractory B…
Beam Therapeutics announced it will present updated Phase 1/2 clinical trial data for ristoglogene autogetemcel (risto-cel), an investigational gene-edited cell therapy aimed at treating sickle cell disease (SCD). The data underscores risto-cel's potential to restore red blood cell health and improve disease pathology by inducing fetal hemoglobin p…
Agios Pharmaceuticals announced new detailed data presentations of mitapivat at the 31st European Hematology Association Congress (EHA 2026). Results from the pivotal RISE UP Phase 3 trial in sickle cell disease demonstrate significant hemoglobin improvements and anti-hemolytic effects. Additional positive long-term data from ENERGIZE trials in tha…
Alpha Compute Corp. announced a definitive two-year lease agreement worth $32.2 million with an unnamed leading AI laboratory for a dedicated deployment of 504 NVIDIA B200 GPUs at its Canadian data center. This contract delivers $16.1 million in annual recurring revenue and marks the company's first enterprise-scale GPUaaS deal, signaling strong de…
Cellectis announced upcoming presentations of Phase 1 clinical trial data for its allogeneic CAR-T therapies lasme-cel and eti-cel at the European Hematology Association Annual Congress 2026. The data highlight promising safety and efficacy in treating relapsed or refractory B-cell malignancies, supporting ongoing pivotal Phase 2 trials with interi…
Moleculin Biotech announced that an independent review by the Cleveland Clinic of pooled data from five clinical trials demonstrates that Annamycin, their next-generation anthracycline for relapsed/refractory acute myeloid leukemia (R/R AML), does not cause clinically significant cardiotoxicity even at cumulative doses exceeding conventional anthra…
21shares has introduced two innovative ETFs on the NASDAQ: the 21shares Hyperliquid ETF (THYP) providing direct spot exposure to HYPE token with staking rewards, and the 21shares 2x Long Hyperliquid ETF (TXXH) offering leveraged exposure. These funds represent the first U.S. ETFs focused on Hyperliquid, a leading decentralized exchange with signifi…
Evaxion A/S announced that it will present new preclinical data for EVX-04, an AI-designed off-the-shelf therapeutic vaccine targeting endogenous retroviral antigens in acute myeloid leukemia (AML), at the European Hematology Association 2026 Congress. The data demonstrate EVX-04's immune response capabilities and tumor growth prevention in preclin…
Uniti Wholesale has quickly demonstrated strong demand for its FastWaves service, securing a customer for eight 400G circuits just two weeks after launch and delivering circuits in 14 days. FastWaves addresses the market need for faster wavelength delivery, particularly driven by AI workloads, hyperscalers, neocloud providers, and large enterprises…
Algorhythm Holdings, a NASDAQ-listed AI-driven logistics solutions provider, will release its Q1 2026 financial results on May 14, 2026, and host a management conference call. The company focuses on its AI-enabled Collaborative Transportation Platform through its subsidiary SemiCab, targeting the global logistics and distribution industry by optimi…
Remitly Global, Inc., a leading provider of cross-border financial services, announced its management team's participation in several upcoming investor events including a post-earnings webinar hosted by Cantor, and presentations at major conferences such as J.P. Morgan Global Technology, Media and Communications Conference, Bernstein Strategic Deci…
Micron Technology has begun sampling its new 256GB DDR5 RDIMM server memory modules built on 1-gamma technology. These modules offer speeds up to 9,200 MT/s, over 40% faster than current products, and feature advanced 3D stacking and through-silicon vias to enhance capacity, speed, and power efficiency, targeting the demands of AI and HPC data cent…
Taboola released a study showing that 76% of advertisers have experienced performance improvements from agentic AI, predominantly within search and social platforms. However, 80% of advertisers are eager to expand AI-driven advertising beyond walled gardens to the open web, with 86% willing to allocate up to 25% of their budgets accordingly. The co…
Opendoor Technologies Inc. announced that CEO Kaz Nejatian will present at the JP Morgan 2026 Global Technology, Media and Communications Conference on May 18, 2026, with a webcast and replay available on their investor relations website. Opendoor operates in the U.S. housing market, providing simplified and faster home buying and selling services.
JAKKS Pacific, in collaboration with Warner Bros. Discovery Global Consumer Products, is releasing an exclusive collector fashion doll line featuring iconic DC characters including Harley Quinn, Poison Ivy, Catwoman, and Supergirl. The collection will be available exclusively at Walmart stores and Walmart.com, marking the first in a series of upcom…
Connect Biopharma Holdings Limited reported its first quarter 2026 financial results and provided an update on its ongoing clinical development of rademikibart for treating acute exacerbations in asthma and COPD. The Phase 2 Seabreeze STAT studies are progressing as planned with no safety concerns identified by the independent DMC. Positive Phase 1…
